Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.16 in the prior trading day, Ernexa Therapeutics Inc (NASDAQ: ERNA) closed at $0.16, up 2.26%. In other words, the price has increased by $2.26 from its previous closing price. On the day, 1.87 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ERNA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when Cherington Charles bought 21,241,163 shares for $0.10 per share. The transaction valued at 2,221,826 led to the insider holds 41,659,743 shares of the business.
Cherington Charles bought 3,768,397 shares of ERNA for $394,174 on Apr 02 ’25. The 10% Owner now owns 20,401,602 shares after completing the transaction at $0.10 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 18.31.
Stock Price History:
Over the past 52 weeks, ERNA has reached a high of $2.62, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is -21.71%, while the 200-Day Moving Average is calculated to be -72.43%.
Shares Statistics:
A total of 52.25M shares are outstanding, with a floating share count of 11.87M. Insiders hold about 80.96% of the company’s shares, while institutions hold 2.39% stake in the company.
